Ventas, Inc. (VTR)
NYSE: VTR · Real-Time Price · USD
87.57
+2.87 (3.39%)
At close: Apr 28, 2026, 4:00 PM EDT
87.88
+0.31 (0.35%)
After-hours: Apr 28, 2026, 6:45 PM EDT

Company Description

Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population.

With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy.

The Company’s growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments.

Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position.

The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities.

Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Ventas, Inc. was incorporated in 1983 in Delaware, USA.

Ventas, Inc.
Ventas logo
Country United States
Founded 1983
IPO Date May 4, 1998
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 542
CEO Debra Cafaro

Contact Details

Address:
300 North LaSalle Street, Suite 1600
Chicago, Illinois 60654
United States
Phone 877 483 6827
Website ventasreit.com

Stock Details

Ticker Symbol VTR
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000740260
CUSIP Number 92276F100
ISIN Number US92276F1003
Employer ID 61-1055020
SIC Code 6798

Key Executives

Name Position
Debra A. Cafaro J.D. Chairman and Chief Executive Officer
Robert F. Probst Executive Vice President and Chief Financial Officer
James Justin Hutchens Executive Vice President of Senior Housing and Chief Investment Officer
Carey Shea Roberts J.D. Executive Vice President, General Counsel, Corporate Secretary and Ethics and Compliance Officer
Peter J. Bulgarelli Executive Vice President of Outpatient Medical and Research
Alex Russo Senior Managing Director of Investments
Bhavana Devulapally Senior Vice President and Chief Information Officer
Bill Grant Senior Vice President of Investor Relations
Timothy Sanders Senior Vice President of Business Development
T. Richard Riney J.D. Senior Advisor

Latest SEC Filings

Date Type Title
Apr 28, 2026 10-Q Quarterly Report
Apr 27, 2026 8-K Current Report
Apr 1, 2026 ARS Filing
Apr 1, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 1, 2026 DEF 14A Other definitive proxy statements
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 2, 2026 144 Filing
Feb 20, 2026 8-K Current Report
Feb 17, 2026 13F-HR Quarterly report filed by institutional managers, holdings
Feb 11, 2026 144 Filing